Angelman UK is a support group led by volunteers – many of which have direct experience of Angelman Syndrome (AS). AS is a rare neurological disorder caused by issues with the UBE3A gene on chromosome 15, leading to developmental delays and speech impairments. The organisation supports families through regional representatives and financial assistance for events. They also fund research projects aimed at understanding AS characteristics and exploring potential treatments. As a founding member of the Angelman Syndrome Alliance, AngelmanUK contributes to funding research for medical treatments and strives to improve the lives of those affected by AS.
Health Innovation Manchester (HInM) is dedicated to improving the lives of local residents, transforming care, and driving economic growth through innovation. Established in 2017, HInM has evolved its operating model to deploy proven innovations at scale, focusing on population health and digital solutions. By fostering partnerships across the NHS, councils, industry, and academia, HInM delivers innovations into frontline care and addresses health and care challenges collaboratively. With a mission to become an international leader in innovation, HInM works to harness the transformative power of health and care, industry, and academia to tackle major challenges and inequalities in Greater Manchester.
The Manchester Centre for Genomic Medicine (MCGM) is a specialised healthcare service focused on genetics and genomics. Staffed by multidisciplinary teams, MCGM offers clinical services, conducts research, and provides education and training in genetics and genomics. With expertise in a diverse range of genetic conditions, MCGM integrates clinical care with cutting-edge research to personalise diagnosis and treatment. As part of the Manchester Biomedical Research Centre, MCGM collaborates with academic scientists to advance precision medicine. Through active research studies and clinical trials, MCGM offers patients access to the latest diagnostic tools and treatment opportunities to improve outcomes.
Manchester Foundation Trust Charity is dedicated to enhancing patient care and experiences within Manchester University NHS Foundation Trust, one of the largest NHS Trusts in the UK, serving over 790,000 people. Through fundraising efforts, they enable the purchase of advanced equipment, fund pioneering medical research, and create welcoming environments for patients and their families. Their vision aligns with the Trust’s goal of improving health and quality of life for the diverse population they serve, achieved through collaboration with hospitals and supporters. Manchester Foundation Trust Charity is committed to ensuring donors have a positive fundraising experience, recognising the importance of every contribution in supporting healthcare excellence in Manchester and the Northwest.
The NIHR Manchester Biomedical Research Centre (BRC) is a noteworthy translational research centre, focusing on converting scientific discoveries into diagnostic tests and treatments. With substantial funding and collaboration with world-class researchers, Manchester BRC aims to drive health improvements and lasting change through proactive research. Their research areas include cancer, inflammation, high-burden under-researched conditions, and disease complexity, with a focus on precision medicine and next-generation therapeutics. By transforming scientific breakthroughs into tangible benefits, Manchester BRC continues to make significant strides in improving healthcare outcomes.
The Manchester Epilepsy Research Network (MERN) aims to understand the mechanisms behind epilepsy and develop effective treatments. It brings together researchers from multiple institutions, including The University of Manchester, Salford Royal Foundation Trust, and Royal Manchester Children’s Hospital. MERN focuses on identifying genetic causes, developing preclinical models, and exploring novel treatments such as gene therapy. The network is committed to improving epilepsy care through clinical trials and collaboration with industry partners
The University of Manchester is a leading institution renowned for its research and innovation across various disciplines. Through collaboration and interdisciplinary approaches, the university drives advancements in knowledge and addresses global challenges. From medical breakthroughs to technological innovations, the University of Manchester contributes to societal progress and improvement. With a focus on excellence in education and research, the university remains committed to making a significant impact on society and shaping the future.
Manchester Museum, one of the largest university museums in the UK, showcases over a century of history and a collection of approximately four and a half million objects encompassing natural sciences and human cultures. Following the completion of the £15 million hello future capital project in February 2023, the museum underwent a transformative renovation focused on caring for people, ideas, beliefs, and relationships. With a commitment to social responsibility, the museum, affiliated with the University of Manchester, actively engages in diverse and interdisciplinary research, social justice initiatives, and anti-poverty work, aiming to address local community needs. By fostering inclusivity, imagination, and care, the museum endeavours to build understanding, empathy, and sustainability, shaping a more equitable and interconnected world for future generations.
Sanofi’s strategy focuses on transforming the practice of medicine by prioritising key medicines, vaccines, and self-care solutions across global business units. With a goal to excel in immunology, the company aims to positively impact millions suffering from immune-mediated diseases. It emphasises advancing breakthrough science through a robust pipeline targeting six therapeutic areas. Additionally, Sanofi is committed to driving social impact by addressing complex societal and environmental challenges. Ultimately, the company aims to build a healthier, more resilient world by discovering, developing, and delivering medicines and vaccines for millions worldwide.
Beacon for Rare Diseases, a UK-based non-profit organisation, is committed to uniting rare disease communities with patient groups at its core. Through patient group training and community projects, it empowers organisations to form, grow, and collaborate effectively. Their vision is a world where no one faces their rare journey alone. By promoting collaboration and advocating for the needs of rare disease patients, they work towards this goal, ensuring that every voice is heard and supported.
The Rare Care Centre in Perth is dedicated to providing comprehensive support for children and adolescents with rare and undiagnosed diseases. It offers statewide cross-sector care coordination, innovative digital solutions, educational initiatives, and family support programs. The Centre also focuses on building clinical research infrastructure and fostering global professional networks. The Rare Care Centre aims to ensure the best possible lives for affected children and their families through holistic care and advocacy.